Table 1

Participants characteristics by treatment arm (for n=836 participants included in the primary analysis)

Arm 1: 50% RDT subsidy and 100% ACT subsidyArm 2: 50% RDT subsidy and 67% ACT subsidyArm 3: RDT no subsidy and 100% ACT subsidyArm 4: RDT no subsidy and 67% ACT subsidyTotal
(n=210)(n=211)(n=213)(n=202)(n=836)
Patient age (years)
 Median (Q1, Q3)30.0 (16.0 to 43.0)31.0 (15.0 to 45.0)30.0 (11.0 to 45.0)28.5 (11.0 to 45.0)30.0 (13.0 to 45.0)
Household size
 Median (Q1, Q3)5.0 (3.0 to 7.0)5.0 (3.0 to 6.0)4.0 (3.0 to 6.0)5.0 (3.0 to 6.0)5.0 (3.0 to 6.0)
Patient age in years % (n)
 0–510.5% (22)12.8% (27)12.7% (27)12.4% (25)12.1% (101)
 >5 to <1815.7% (33)14.2% (30)20.2% (43)19.8% (40)17.5% (146)
 18 to <3534.3% (72)28.0% (59)21.6% (46)27.2% (55)27.8% (232)
 35+39.5% (83)45.0% (95)45.5% (97)40.6% (82)42.7% (357)
Patient gender % (n)
 Female43.8% (92)49.0% (103)45.5% (97)47.5% (96)46.5% (388)
 Male56.2% (118)51.0% (107)54.5% (116)52.5% (106)53.5% (447)
 Missing(0)(1)(0)(0)(1)
Highest level of education completed % (n)
 <Primary or none21.0% (44)16.1% (34)19.7% (42)19.3% (39)19.0% (159)
 Complete primary41.9% (88)32.2% (68)34.7% (74)33.2% (67)35.5% (297)
 Complete secondary37.1% (78)51.7% (109)45.5% (97)47.5% (96)45.5% (380)
Occupation % (n)
 Farming19.5% (41)23.8% (50)24.9% (53)19.8% (40)22.0% (184)
 Unemployed17.6% (37)15.2% (32)13.6% (29)17.3% (35)15.9% (133)
 Formally employed13.3% (28)17.6% (37)15.0% (32)10.4% (21)14.1% (118)
 Self-employed42.9% (90)41.4% (87)39.4% (84)45.5% (92)42.3% (353)
 Informal employment6.7% (14)1.9% (4)7.0% (15)6.9% (14)5.6% (47)
Missing(0)(1)(0)(0)(1)
Wealth: lower 40th percentile % (n)
 >40th percentile56.9% (119)61.9% (130)60.3% (126)60.7% (119)60.0% (494)
 0–40th percentile43.1% (90)38.1% (80)39.7% (83)39.3% (77)40.0% (330)
 Missing(1)(1)(4)(6)(12)
  • Age is for the sick individual and education level is for respondents over the age of 18 (either the sick individual or the parent/guardian for minor participants). Q1 and Q3 correspond the 25th and 75th percentile, respectively.

  • ACT, artemisinin-combination therapy; RDT, rapid diagnostic test.